Down regulation of estrogen receptor expression is an early event in human papillomavirus infected cervical dysplasia

European Journal of Gynaecological Oncology

Volumn 26, Issue 4, 2005, Pages 376-382

  Bekkers, R L M ^a   Van Der Avoort, I A M ^a   Melchers, W J G ^a   Bulten, J ^a   De Wilde, P C M ^a   Massuger, L F A G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical dysplasia; Estrogen receptor; Hyperproliferation; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; STEROID HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HIGH RISK POPULATION; HORMONE SENSITIVITY; HUMAN; LABELING INDEX; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; UTERINE CERVICITIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX DYSPLASIA; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ADULT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, ESTROGEN; UTERINE CERVICAL DYSPLASIA;

EID: 23744482279     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Herrington C.S.: "Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology". J. Clin. Pathol., 1994, 47, 1066.
2. Chan S.Y., Delius H., Halpern A.L., Bernard H.U.: "Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy". J. Virol., 1995, 69, 3074.
3. Meijer C.J.L.M., Rozendaal R., Verheijen R.M., Walboomers J.M.M.: "Clinical role of HPV testing". C.M.E. J. Gynecol. Oncol., 2000, 5, 26.
4. Walboomers J.J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer A., Shah K.V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 12.
5. Klaes R., Woerner S.M., Ridder R., Wentzensen N., Duerst M., Schneider A. et al.: "Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes". Cancer Res., 1999, 59, 6132.
6. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V.: "The causal relation between human papillomavirus and cervical cancer". J. Clin. Pathol., 2002, 55, 244.
7. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V. et al.: "Epidemiologic classification of human papillomavirus types associated with cervical cancer". N. Eng. J. Med., 2003, 348, 518.
8. Konishi I., Fujii S., Nonogaki H., Nanbu Y., Iwai T., Mori T.: "Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix". Cancer, 1991, 68, 1340.
9. Bulten J., van der Laak J.A., Gemmink J.H., Pahlplatz M.M., de Wilde P.C., Hanselaar A.G.: "MIB-1, a promising marker for the classification of cervical intraepithelial neoplasia". J. Pathol., 1996, 178, 268.
10. McCluggage W.G., Buhidma M., Tang L., Maxwell P., Bharucha H.: "Monoclonal antibody MIB-1 in the assessment of cervical squamous intraepithelial lesions". Int. J. Gynecol. Pathol., 1996, 75, 131.
11. Al-Saleh W., Delvenne P., Greimers R., Fridman V., Doyen J., Boniver J.: "Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Correlation with the histologic grade and human papillomavirus type". Am. J. Clin. Pathol., 1995, 104, 154.
12. Kim C.J., Um S.J., Kim T.Y., Kim E.J., Park T.C., Kim S.J. et al.: "Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells". Int. J. Gynecol. Cancer, 2000, 10, 157.
13. Smith J.S., Green J., Berrington de Gonzalez A., Appleby P., Peto J., Plummer M., Franceschi S., Beral V.: "Cervical cancer and use of hormonal contraceptives: a systematic review". Lancet, 2003, 361, 1159.
14. Robertson D.I., Paslawski D., Duggan M.A., Stuart G.C., Nation J.G.: "Estrogen and progesterone receptor, human papillomavirus, and DNA ploidy analysis in invasive carcinoma of the cervix in pregnancy". Am. J. Clin. Pathol., 1993, 100, 18.
15. Monsonego J., Magdelenat H., Catalan F., Coscas Y., Zerat L., Sastre X.: "Estrogen and progesterone receptors in cervical human papillomavirus related lesions". Int. J. Cancer, 1991, 48, 533.
16. Nonogaki H., Fujii S., Konishi I., Nanbu Y., Ozaki S., Ishikawa Y., Mori T.: "Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix". Cancer, 1990, 66, 2620.
17. Kanai M., Shiozawa T., Xin L., Nikaido T., Fujii S.: " Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix". Cancer, 1998, 82, 1709.
18. Tervahauta A., Syrjanen S., Syrjanen K.: "Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human papillomavirus lesions of the uterine cervix". Int. J. Gynecol. Pathol., 1994, 13, 234.
19. Coelho F.R.G., Prado J.C.M., Pereira Sobrinho J.S., Hamada G., Landman G. et al.: "Estrogen and progesterone receptors in human papilloma virus-related cervical neoplasia". Braz. J. Med. Biol. Res., 2004, 37, 83.
20. Fonseca-Moutinho J.A., Cruz E., Carvalho L., Prazeres H.J.M., De Lacerda M.M.P., Da Silva D.P. et al.: "Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III". Int. J. Gynecol. Cancer, 2004, 14, 911.
21. Melchers W.J., Bakkers J.M., Wang J., de Wilde P.C.M., Boonstra H., Quint W.G.V. et al.: "Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up". Am. J. Pathol., 1999, 155, 1473.
22. Kleter B., van Doom L.J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M. et al.: "Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses". Am. J. Pathol., 1998, 153, 1731.
23. Kleter B., van Doom L.J., Schrauwen L., Molijn A., Sastrowijoto S., ter Schegget J. et al.: "Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for j detection and identification of anogenital human papillomavirus". J. Clin. Microbiol., 1999, 37, 2508.
24. Quint W.G., Scholte G., van Doom L.J., Kleter B., Smits P.M., Lindeman J.: "Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping". J. Pathol., 2001, 194, 51.
25. Bekkers R.L.M., Melchers W.J.G., Bulten J., Hanselaar A.J.G.M., Quint W.G.V., Boonstra H., Massuger L.F.A.G.: "Localized distribution of human papillomavirus genotypes in the uterine cervix". Eur. J. Gynaecol. Oncol., 2002, 23, 203.
26. Monsonego J., Valensi P., Zerat L., Clavel C., Birembaut P.: "Simultaneous effects of aneuploidy and oncogenic human papillomavirus on histological grade of cervical intraepithelial neoplasia". Br. J. Obstet. Gynaecol., 1997, 104, 723.
27. th edition. Baltimore, Williams & Wilkins, 1994.
28. th edition, Stanford CT, Appleton & Lange, 1997.
29. Bulten J., de Wilde P.C., Boonstra H., Gemmink J.H., Hanselaar A.G.: "Proliferation in 'atypical' atrophic pap smears". Gynecol. Oncol, 2000, 79, 225.
30. Burghardt E., Ostor A.G.: "Site and origin of squamous cervical cancer: a histomorphological study". Obstet. Gynecol., 1983, 62, 117.
31. Park J., Sun D., Genest D.R., Trivijitsilp P., Suh I., Crum C.P.: "Coexistence of low and high grade squamous intraepithelial lesions of the cervix: Morphologic progression or multiple papillomaviruses?". Gynecol. Oncol., 1998, 70, 386.